Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Animal Study

The results of this study suggest that Lactobacillus strains could be used as a protective strategy against mycotoxin cytotoxicity.

Revitalizing health with Lactobacillus isolates: Mitigating Aflatoxin B1 toxicity in HT-29 cell line and Balb/c mice.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

293 views
Share:

Abstract

AIM: Aflatoxins, carcinogenic mycotoxins found in fermented foods, animal GITs, and the environment, can be detoxified by probiotic lactobacilli. The aim of this study was to test whether probiotic lactobacilli can detoxify aflatoxins, carcinogenic mycotoxins prevalent in fermented foods, animal gastrointestinal tracts (GITs), and the environment. METHODS AND RESULTS: Five candidate Lactobacillus strains (Lacticaseibacillus rhamnosus 195 (G1), Lactiplantibacillus plantarum 42 (G2), Levilactobacillus brevis 205 (G3), L. plantarum 165 (G4), and Limosilactobacillus reuteri 100 (G5)) were prepared to compare their ability to reduce AFB1 in vitro and in vivo by evaluating apoptotic factors, inflammatory markers, tight junction, and nutrient transport genes. G1, G2, G3, G4, and G5 bound AFB1 well (with no notable variations). These probiotic isolates lowered Bax and caspase-3 expression in AFB1-treated HT-29 cells and raised Bcl-2 expression. In AFB1-treated cells, these probiotics increased Occludin and Zonula occludens-1 (ZO-1) expression as tight junction markers. In contrast, Lactobacillus strains + AFB1-treated cells expressed fewer nutritional transport genes (amino acid transporter 2, glucose transporter 2, peptide transporter 1, sodium-dependent glucose cotransporter 1) and Interleukin-6, an inflammatory marker. In animal models, oral lactobacillus supplementation reduced AFB1-induced liver injury and increased GST A3 expression via the Nrf2 pathway. These Lactobacillus isolates also reduced CYP 450 1A2 and 3A4 expression. CONCLUSIONS: The results of this study suggest that Lactobacillus strains could be used as a protective strategy against mycotoxin cytotoxicity by promoting the maintenance of standard intestinal cell structure and function and the health of animal models.

Affiliation

Atieh Darbandi

External References

PubMed ID:
40874752

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

More Research Abstracts

View All Abstracts

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.